Liver Trauma: Until When We Have to Delay Surgery? A Review
Overview
Authors
Affiliations
Liver involvement after abdominal blunt trauma must be expected, and in up to 30% of cases, spleen, kidney, and pancreas injuries may coexist. Whenever hemodynamics conditions do not contraindicate the overcoming of the ancient dogma according to which exploratory laparotomy should be performed after every major abdominal trauma, a CT scan has to clarify the liver lesions so as to determine the optimal management strategy. Except for complete vascular avulsion, no liver trauma grade precludes nonoperative management. Every attempt to treat the injured liver by avoiding a strong surgical approach may be considered. Each time, a nonoperative management (NOM) consisting of a basic "wait and see" attitude combined with systemic support and blood replacement are inadequate. Embolization should be considered to stop the bleeding. Percutaneous drainage of collections, endoscopic retrograde cholangiopancreatography (ERCP) with papilla sphincterotomy or stent placement and percutaneous transhepatic biliary drainage (PTBD) may avoid, or at least delay, surgical reconstruction or resection until systemic and hepatic inflammatory remodeling are resolved. The pathophysiological principle sustaining these leanings is based on the opportunity to limit the further release of cell debris fragments acting as damage-associated molecular patterns (DAMPs) and the following stress response associated with the consequent immune suppression after trauma. The main goal will be a faster recovery combined with limited cell death of the liver through the ischemic events that may directly follow the trauma, exacerbated by hemostatic procedures and surgery, in order to reduce the gross distortion of a regenerated liver.
Tosa V, Ilie-Ene A, Tripon S, Mesaros A, Fechete R, Tosa N Materials (Basel). 2024; 17(17).
PMID: 39274707 PMC: 11396440. DOI: 10.3390/ma17174318.
The impact of augmenter of liver regeneration in blunt liver trauma: An experimental model analysis.
Kavak N, Akcan G, Balci N, Suer A, Guler I, Kavak R Ulus Travma Acil Cerrahi Derg. 2024; 30(7):472-479.
PMID: 38967532 PMC: 11331352. DOI: 10.14744/tjtes.2024.92575.
Mena Albors L, Reiss S, Shen A, Ang D Cureus. 2023; 15(7):e41436.
PMID: 37546026 PMC: 10404113. DOI: 10.7759/cureus.41436.
Multicellular Liver Organoids: Generation and Importance of Diverse Specialized Cellular Components.
Ietto G, Iori V, Gritti M, Inversini D, Costantino A, Izunza Barba S Cells. 2023; 12(10).
PMID: 37408262 PMC: 10217024. DOI: 10.3390/cells12101429.
Mitricof B, Kraft A, Anton F, Barcu A, Barzan D, Haiducu C World J Clin Cases. 2023; 11(16):3837-3846.
PMID: 37383130 PMC: 10294146. DOI: 10.12998/wjcc.v11.i16.3837.